Status:
UNKNOWN
Liver Transplantation and Metastatic Colo-rectal Cancer.
Lead Sponsor:
Oslo University Hospital
Conditions:
Colo-rectal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Survival of colo-rectal cancer patients after liver transplantation.
Detailed Description
Survival, time to progression, other malignancy, side-effects, quality of life.
Eligibility Criteria
Inclusion
- Colo-rectal cancer -
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00294827
Start Date
February 1 2006
End Date
March 1 2024
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rikshospitalet-Radiumhospitalet HF
Oslo, Norway, 0020